Why Did Philip Morris (PM) Rise After Cutting Its 2026 Profit Forecast Again?
Philip Morris International (PM) shares rose after the company cut its 2026 adjusted profit forecast for a third time on July 22. The cut reflected a smaller currency benefit, while results beat estimates, helped by stronger-than-expected cigarette volumes. International smoke-free revenue grew organically, and ZYN shipments improved sequentially after an FDA modified-risk authorization for 20 products.
How this was made
The 30-second read
Why it matters
Traders are likely to reprice PM based on whether the guidance cut is primarily translation/currency versus a true deterioration in underlying earnings power, with ZYN economics and margin trajectory as the main uncertainty.
Market read
The article frames PM’s post-guidance rally as a debate between currency/combustible strength versus ongoing U.S. ZYN margin pressure and higher investment needs.
What to watch
Currency effects are explicitly cited as a major component of the forecast revision, so FX moves could reverse the perceived “look-through” benefit; also, the FDA authorization covers only part of the ZYN portfolio, limiting how much marketing advantage can translate into sustained share gains.
Background
PM cut its 2026 adjusted earnings forecast for the third time in 2026, but the stock rose on July 22 despite the guidance reduction.
Ticker impact
Philip Morris cut its 2026 adjusted profit forecast again, yet shares rose after a cigarette-volume beat and a smaller currency drag.
Choppy to mildly positive near term; follow-through depends on whether ZYN profitability and category capture improve versus the bear-case margin pressure.
The article provides concrete drivers for the rally (cigarettes volume +1.1%, currency benefit down only five cents, FDA modified-risk authorization) and concrete bear risks (U.S. revenue -0.7%, adjusted gross profit -9%, margin -6 pts, ZYN offtake flat/slightly up).
Market effects
Signals that combustible earnings can temporarily offset nicotine-pouch margin pressure, influencing how investors price tobacco diversification and smoke-free transition risk.
U.S. ZYN economics are the key swing factor, so U.S. consumer/nicotine sentiment and regulatory expectations can drive PM volatility.
International smoke-free growth (IQOS/VEEV) supports a global diversification thesis, potentially stabilizing sentiment across large tobacco peers.
Counterpoint
The rally may be over-weighting a one-quarter combustible outperformance while underestimating the cost and pricing actions needed to defend ZYN share and margins.
Key entities
- companyPhilip Morris International Inc.
Subject of the article; cut 2026 adjusted earnings forecast again, while cigarettes and international smoke-free performance supported the stock reaction.
- regulatorFDA
Granted modified-risk marketing authorization to 20 ZYN products on June 30, strengthening PM’s regulatory position.
- product_brandZYN
U.S. nicotine pouch franchise whose shipments show sequential recovery but profitability and category capture remain contested.
